Skip to content
Baker Capital StrategiesMARKETS. FILINGS. PERSPECTIVE.
Powered by THEMA

BAKER CAPITAL STRATEGIES

Get the free weekly BCS email.

Selected company filings and market updates, delivered by email. Your first report will follow soon.

  • Your weekly BCS reportMarket updates and links to filings you can explore.
  • THEMA at launchWe’ll send directions for setting up your filing alerts when THEMA officially opens.

One signup for the weekly email and your free THEMA Basic account at launch.

Already registered or a CSW member?Log in to THEMA →

At least 8 characters. This also creates your free THEMA account for launch.

You’re signing up for the weekly BCS email and THEMA launch/setup updates. Unsubscribe using the link in any email. Privacy policy · Terms

BCS

Notice of Proposed Sale · 144

CareDx, Inc.

CDNANASDAQEQUITYCurrent

Notice of Proposed Sale

Filed Aug 4, 2026Accepted Aug 4, 2026, 4:28 PM EDTFiling CIK 1217234Accession 0001950047-26-007618
Share

Structured filing — 144

primary_doc.xml

Open full document ↗

Notice of proposed sale. The proposed amounts below do not establish that a sale occurred.

Proposed-sale notice

Issuer
CAREDX, INC.
Issuer CIK
0001217234
SEC file number
001-36536
Phone
415-287-2300
Person for whose account securities are to be sold
MICHAEL D. GOLDBERG FAM TRUST
Relationships to issuer
Director
Street
8000 Marina Boulevard,
City
Brisbane
State / country code
CA
Postal code
94005

Securities proposed for sale

Securities proposed for sale · 1 reported row
SecurityProposed unitsAggregate market valueUnits outstandingApproximate sale dateExchangeBroker / market maker
Common44,7002,103,497.0751,734,00008/04/2026NASDAQMorgan Stanley Smith Barney LLC Executive Financial Services

Broker / market maker — proposed row 1, entry 1

Name
Morgan Stanley Smith Barney LLC Executive Financial Services
Street
1 New York Plaza
Street (continued)
8th Floor
City
New York
State / country code
NY
Postal code
10004

Acquisition of securities to be sold

Acquisition of securities to be sold · 24 reported rows
SecurityAcquiredNature of acquisitionAcquired fromAmount acquiredGift transactionPayment dateNature of payment
Common01/05/2022Restricted Stock Vesting Under a Registered PlanIssuer699N01/05/2022Compensation
Common01/06/2023Restricted Stock Vesting Under a Registered PlanIssuer2,896N01/06/2023Compensation
Common01/06/2026Restricted Stock Vesting Under a Registered PlanIssuer1,492N01/06/2026Compensation
Common09/30/2022Restricted Stock Vesting Under a Registered PlanIssuer1,419N09/30/2022Compensation
Common01/04/2021Restricted Stock Vesting Under a Registered PlanIssuer629N01/04/2021Compensation
Common07/02/2026Restricted Stock Vesting Under a Registered PlanIssuer1,746N07/02/2026Compensation
Common01/01/2014Restricted Stock Vesting Under a Registered PlanIssuer12,500N01/01/2014Compensation
Common07/08/2025Restricted Stock Vesting Under a Registered PlanIssuer1,218N07/08/2025Compensation
Common04/01/2021Restricted Stock Vesting Under a Registered PlanIssuer470N04/01/2021Compensation
Common04/04/2025Restricted Stock Vesting Under a Registered PlanIssuer967N04/04/2025Compensation
Common07/08/2024Restricted Stock Vesting Under a Registered PlanIssuer2,963N07/08/2024Compensation
Common04/04/2024Restricted Stock Vesting Under a Registered PlanIssuer3,534N04/04/2024Compensation
Common04/05/2022Restricted Stock Vesting Under a Registered PlanIssuer1,000N04/05/2022Compensation
Common04/02/2026Restricted Stock Vesting Under a Registered PlanIssuer1,981N04/02/2026Compensation
Common06/18/2021Restricted Stock Vesting Under a Registered PlanIssuer3,189N06/18/2021Compensation
Common07/07/2021Restricted Stock Vesting Under a Registered PlanIssuer459N07/07/2021Compensation
Common01/06/2025Restricted Stock Vesting Under a Registered PlanIssuer856N01/06/2025Compensation
Common04/01/2020Restricted Stock Vesting Under a Registered PlanIssuer1,086N04/01/2020Compensation
Common10/06/2025Restricted Stock Vesting Under a Registered PlanIssuer1,753N10/06/2025Compensation
Common01/02/2020Restricted Stock Vesting Under a Registered PlanIssuer273N01/02/2020Compensation
Common06/16/2022Restricted Stock Vesting Under a Registered PlanIssuer1,127N06/16/2022Compensation
Common10/01/2021Restricted Stock Vesting Under a Registered PlanIssuer479N10/01/2021Compensation
Common10/04/2024Restricted Stock Vesting Under a Registered PlanIssuer837N10/04/2024Compensation
Common07/01/2022Restricted Stock Vesting Under a Registered PlanIssuer1,127N07/01/2022Compensation

Prior-sale reporting

Nothing to report for the preceding three months
Y

Notice signature

Notice date
08/04/2026
Signed
/s/ Michael Goldberg, Trustee

Company context

CareDx is a precision medicine company dedicated to improving outcomes for transplant patients and advancing organ health. The Company’s integrated solutions include non invasive molecular testing for heart, kidney, and lung transplants; laboratory products; digital health technologies; and patient solutions that support care before and after transplant. CareDx is the leading provider of genomics based information for transplant patients. For more information, please visit www.caredx.com.

Current securities

Recent company filings

  1. 10-Q filingOct 29, 2026
  2. Results of Operations and Financial Condition · Regulation FD DisclosureOct 29, 2026
  3. Completion of Acquisition or Disposition of AssetsSep 16, 2026
  4. 144 filingAug 17, 2026
  5. 144 filingAug 14, 2026

Privacy choices

BCS measures page use with Google Analytics using regional consent settings. You can change your preference here. Charts and market data remain available.

Essential functions — always available. Security, navigation, registration and remembering these choices.

Audience analytics

Analytics cookies are off by default for visitors Google identifies in the EEA, UK or Switzerland until allowed. Limited measurement without analytics cookies may still occur under those regional defaults.

TradingView charts, quotes and the economic calendar load automatically as page content. TradingView receives network and browser information and may collect its own usage analytics. This choice controls BCS’s Google Analytics only.

Google advertising is not enabled. Direct sponsor links do not load advertising trackers on BCS.

Turning analytics off stops future Google Analytics activity here. It does not erase information already received by the provider. Read the privacy policy.